News & Media — Team


Marielle Todd Joins as Research & Marketing Intern

We are delighted to welcome Marielle Todd to our team as a research and marketing intern. Marielle is currently pursuing her BA in Business Administration, alongside a Master of International Business at the University of Florida – Warrington College of Business. Marielle brings an academic specialisation in Entrepreneurship, coupled with valuable experience in marketing and …

Priyanka Seegobin joins as MBA Intern

We’re delighted to announce that Priyanka Seegobin has joined our team this summer as an MBA intern! Priyanka brings a wealth of experience to the table. Currently pursuing her MBA at Stanford University Graduate School of Business, she comes with five years of clinical development experience at Novo Nordisk in both drugs and device delivery. …

Attending the Decoding the Future of Women Conference
Sabrina Franco
Product Development Engineer

Thrilled to represent Calla Lily Clinical Care at the Decoding the Future of Women conference. It was an inspiring day filled with groundbreaking insights at the intersection of technology and women’s health. Standouts: Beyond the presentations, the conference was about connections and stories. Every innovation has a tale to tell. I had the pleasure of …

Dr. Arturo Jose Mendoza Meinhardt Joins as Senior Scientist

Welcome to Arturo Jose Mendoza Meinhardt, PhD who joins our team as a Senior Scientist. Arturo is a biomaterials scientist and engineer with expertise in medical device development, analytical characterisation, and drug delivery formulations (including 18 months prior experience with our Callavid technology working as a consultant).  We’re delighted to have you on-board!

Welcoming Dr. Janet Halliday to Calla Lily Clinical Care’s New Labs and Offices

Our CMC (Chemistry, Manufacturing and Controls) Advisor Dr Janet Halliday had her first visit to Calla Lily Clinical Care’s new labs and offices. It was particularly inspiring for members of our team to hear about Janet’s journey and decades of vaginal drug delivery knowledge, starting as a formulation scientist for a university spinoff and progressing to the …

Dr. Elham Shirani Joins as Biomedical Engineer

Welcome to Elham Shirani, PhD who joins our team as a Biomedical Engineer.  Elham is a recent PhD graduate from Macquarie University, where she brings her passion for FemTech and expertise in surface engineering & polymeric membrane/material modification to our vaginal drug delivery platform. We’re delighted to have you on-board!

Attending the FemTech Forward 2024 Conference

Team members Thang Vo-Ta and Kaylie Mings represented Calla Lily at the FemTech Conference held at University of Oxford. Besides Thang’s presentation on the progress of our Callavid drug delivery & Lilyvid sample collection technologies, there were also more personal sharings with the wider community at an innovation showcase held in the observatory building of …

Sabrina Franco Joins as Product Development Engineer

Welcome to Sabrina Franco who joins our team as a Product Development Engineer. As a recent graduate from Imperial College London and Boston University, she brings a passion for impactful solutions for womens health. We’re delighted to have you on-board!

Attending the Inaugral Microbes in Women’s Health Congress

Our Principal Scientist Andrew Lewis and Co-Founder Thang Vo-Ta recently took part in the inaugural Microbes in Women’s Health Congress in Copenhagen! They attended superb seminars/presentations, had great catch-ups and forged new & important connections in the groundbreaking microbiome space.  The unfolding science is getting undeniable: reproductive tract dysbiosis or the lack of a healthy …

Attending the Launch of Tommy’s National Centre for Preterm Birth Research

It was wonderful for members of our team to celebrate Tommy’s launch of their amazing new preterm birth centre. Always energising and inspiring to be in a room full of clinicians, researchers, midwives, engineers, supporters, and those with lived experience – for such an important cause.   We are excited about how impactful our Callavid device will …

We use cookies to enhance your website experience. We use necessary cookies to ensure our website functions properly and to keep it secure. These always need to be on. By clicking “Accept cookies”, you agree to the storing of cookies on your device to enhance site navigation, analyse site usage, and assist in our marketing efforts. Please view our privacy policy for further details.